Discover this podcast and so much more

Podcasts are free to enjoy without a subscription. We also offer ebooks, audiobooks, and so much more for just $11.99/month.

Why therapy? Therapy Modalities & Radical Acceptance: 2024 Eye on Mental Health Session 2

Why therapy? Therapy Modalities & Radical Acceptance: 2024 Eye on Mental Health Session 2

FromThe Eye Believe Podcast


Why therapy? Therapy Modalities & Radical Acceptance: 2024 Eye on Mental Health Session 2

FromThe Eye Believe Podcast

ratings:
Length:
52 minutes
Released:
Feb 15, 2024
Format:
Podcast episode

Description

Ocular Melanoma is enough to justify extra support. Dr. Allison Dashow, a patient and psychologist, shares a summary of therapies patients may find supportive, emphasizing the skills that can be developed to reach a point of radical acceptance in your diagnosis.

Dr. Allie Dashow is a clinical psychologist and has been seeing clients for psychotherapy and group therapy for the past 6 years. She specializes in the following therapy modalities: cognitive behavioral therapy, dialectical behavioral therapy, and acceptance and commitment therapy. Allie also specializes in eating disorders and body image difficulties. She has run multiple psychoeducational trainings for colleagues and early career therapists, workshops for students, and therapy groups relating to eating disorders, disordered eating, and body image challenges. In her spare time, she also spent 8 years as a senior administrator for Beating Eating Disorders, an online based platform with over 150,000 followers that aims to raise eating disorder awareness and provide support and resources to those in need. On the side, Allie also provides executive functioning coaching for people with ADHD.


Our mini seminar this year was brought to you by Castle Biosciences, as well as Aura Biosciences, Immunocore, IDEAYA Biosciences, Delcath Systems, and Trisalus Life Sciences. 
Released:
Feb 15, 2024
Format:
Podcast episode

Titles in the series (100)

Sharing information and insights on treatment, research, and living with ocular melanoma.